These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36075392)

  • 21. Austrian recommendations for the management of essential thrombocythemia.
    Buxhofer-Ausch V; Heibl S; Sliwa T; Beham-Schmid C; Wolf D; Geissler K; Krauth MT; Krippl P; Petzer A; Wölfler A; Melchardt T; Gisslinger H
    Wien Klin Wochenschr; 2021 Jan; 133(1-2):52-61. PubMed ID: 33215234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.
    Agarwal MB; Malhotra H; Chakrabarti P; Varma N; Mathews V; Bhattacharyya J; Seth T; Gayathri K; Menon H; Subramanian PG; Sharma A; Bhattacharyya M; Mehta J; Vaid AK; Shah S; Aggarwal S; Gogoi PK; Nair R; Agarwal U; Varma S; Prasad SV; Manipadam MT
    Indian J Med Paediatr Oncol; 2015; 36(1):3-16. PubMed ID: 25810569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology and Current Treatment of Myeloproliferative Neoplasms.
    Ali H; Pullarkat V; Snyder D
    Cancer Treat Res; 2021; 181():151-165. PubMed ID: 34626360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ; Thiele J
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The myeloproliferative disorders.
    Gilbert HS; Dameshek W
    Dis Mon; 1970 Oct; ():1-52. PubMed ID: 4921953
    [No Abstract]   [Full Text] [Related]  

  • 27. [Research status and challenges of advanced myeloproliferative neoplasms].
    Bai J; Zhang YH; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3603-3607. PubMed ID: 38018058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contemporary approach to essential thrombocythemia and polycythemia vera.
    Aruch D; Mascarenhas J
    Curr Opin Hematol; 2016 Mar; 23(2):150-60. PubMed ID: 26717193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing disease burden in patients with classic MPNs.
    Geyer H; Mesa RA
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):107-19. PubMed ID: 25189722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis.
    Moura LG; Tognon R; Nunes NS; Rodrigues LC; Ferreira AF; Kashima S; Covas DT; Santana M; Souto EX; Perobelli L; Simões BP; Dias-Baruffi M; Castro FA
    J Clin Pathol; 2016 Oct; 69(10):926-9. PubMed ID: 27402956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifestyle factors and risk of myeloproliferative neoplasms in the NIH-AARP diet and health study.
    Podoltsev NA; Wang X; Wang R; Hofmann JN; Liao LM; Zeidan AM; Mesa R; Ma X
    Int J Cancer; 2020 Aug; 147(4):948-957. PubMed ID: 31904114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany.
    Schmidt A; Bernhardt C; Bürkle D; Fries S; Hannig CV; Jentsch-Ullrich K; Josting A; Kreher S; Reiser M; Steinmetz HT; Tesch H; Terner S; Schulte A; Crodel CC; Palandri F; Heidel FH
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7197-7206. PubMed ID: 36884118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL; Ortiz-Hidalgo C
    Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of myeloproliferative disorders.
    Laszlo J; Huang AT
    Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.
    Delic S; Rose D; Kern W; Nadarajah N; Haferlach C; Haferlach T; Meggendorfer M
    Br J Haematol; 2016 Nov; 175(3):419-426. PubMed ID: 27447873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms.
    Mora B; Passamonti F
    Curr Hematol Malig Rep; 2022 Oct; 17(5):127-139. PubMed ID: 36048275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing myelofibrosis from polycythemia vera and essential thrombocythemia: The utility of enumerating circulating stem cells with aberrant hMICL expression by flow cytometry.
    Herborg LL; Nederby L; Hasselbalch HC; Aggerholm A; Roug AS
    Int J Lab Hematol; 2018 Jun; 40(3):320-325. PubMed ID: 29427319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities.
    Coltro G; Loscocco GG; Vannucchi AM
    Int Rev Cell Mol Biol; 2021; 365():1-69. PubMed ID: 34756241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocytosis and MPNs: Where do we stand?
    Coltoff A
    Leuk Lymphoma; 2023 Mar; 64(3):564-572. PubMed ID: 36519233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy.
    Tefferi A
    Am J Hematol; 2008 Jun; 83(6):491-7. PubMed ID: 18429051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.